Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Curigliano

Showing results (11-20 of 190) with videos related to

Pageof 19
Sort By:
ESMO Open|March 27, 2026
A machine learning assay to predict disease recurrence in hormone receptor-positive breast cancerL Boscolo Bielo, D Trapani, P Razavi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Gemcitabine-induced systemic capillary leak syndromeT De Pas, G Curigliano, L Franceschelli, et al.
Breast (Edinburgh, Scotland)|July 30, 2018
Perspectives on preoperative systemic treatment and breast conservative surgery: One step forward or two steps back?I T Rubio, L Wyld, F Cardoso, et al.
ESMO Open|February 22, 2023
How I treat endocrine-dependent metastatic breast cancerA Gombos, A Goncalves, G Curigliano, et al.
ESMO Open|April 13, 2024
Open questions, current challenges, and future perspectives in targeting human epidermal growth factor receptor 2-low breast cancerG Curigliano, R Dent, H Earle, et al.
ESMO Open|June 23, 2022
Quantifying geographical accessibility to cancer clinical trials in different income landscapesG Tini, D Trapani, B A Duso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancerS Fogli, R Danesi, F De Braud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 13, 2023
Patient-reported outcomes and hospitalization data in patients with HER2-positive metastatic breast cancer receiving trastuzumab deruxtecan or trastuzumab emtansine in the phase III DESTINY-Breast03 studyG Curigliano, K Dunton, M Rosenlund, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Immunohistochemical analysis of p53 protein in transplant recipients with Kaposi's sarcomaG Flamini, S Magalini, G Curigliano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2021
Seroconversion rate after vaccination against COVID-19 in patients with cancer-a systematic reviewC Corti, G Antonarelli, F Scotté, et al.
Pageof 19

Showing results (11-20 of 190) with videos related to

Sort By:
Pageof 19
ESMO Open|March 27, 2026
A machine learning assay to predict disease recurrence in hormone receptor-positive breast cancerL Boscolo Bielo, D Trapani, P Razavi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Gemcitabine-induced systemic capillary leak syndromeT De Pas, G Curigliano, L Franceschelli, et al.
Breast (Edinburgh, Scotland)|July 30, 2018
Perspectives on preoperative systemic treatment and breast conservative surgery: One step forward or two steps back?I T Rubio, L Wyld, F Cardoso, et al.
ESMO Open|February 22, 2023
How I treat endocrine-dependent metastatic breast cancerA Gombos, A Goncalves, G Curigliano, et al.
ESMO Open|April 13, 2024
Open questions, current challenges, and future perspectives in targeting human epidermal growth factor receptor 2-low breast cancerG Curigliano, R Dent, H Earle, et al.
ESMO Open|June 23, 2022
Quantifying geographical accessibility to cancer clinical trials in different income landscapesG Tini, D Trapani, B A Duso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancerS Fogli, R Danesi, F De Braud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 13, 2023
Patient-reported outcomes and hospitalization data in patients with HER2-positive metastatic breast cancer receiving trastuzumab deruxtecan or trastuzumab emtansine in the phase III DESTINY-Breast03 studyG Curigliano, K Dunton, M Rosenlund, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Immunohistochemical analysis of p53 protein in transplant recipients with Kaposi's sarcomaG Flamini, S Magalini, G Curigliano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2021
Seroconversion rate after vaccination against COVID-19 in patients with cancer-a systematic reviewC Corti, G Antonarelli, F Scotté, et al.
Pageof 19